** Shares of biotech firm Virpax Pharmaceuticals VRPX.O fall 55.2% to 54 cents
** VRPX's stock to be delisted from Nasdaq tomorrow for failing to meet minimum stockholders' equity requirement - SEC filing
** Co does not plan to appeal the delisting decision
** Three board members and CFO, Usama Chaudhry, have resigned from their positions, effective immediately
** Including session's move, stock down 94% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。